CA2906558A1 - Procede et appareil pour stimulation transdermique sur les surfaces palmaires et plantaires - Google Patents

Procede et appareil pour stimulation transdermique sur les surfaces palmaires et plantaires

Info

Publication number: CA2906558A1
Authority: CA; Canada
Prior art keywords: stimulation; nerve; applicator; sensor; electrode
Prior art date: 2013-03-15
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA2906558A

Other languages

English (en)

Inventor

Amit Rajguru

Daniel Rogers Burnett

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

EMKinetics Inc

Original Assignee

EMKinetics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-03-15

Filing date

2014-03-13

Publication date

2014-09-25

2013-03-15 Priority claimed from US13/840,936 external-priority patent/US9339641B2/en

2014-03-13 Application filed by EMKinetics Inc filed Critical EMKinetics Inc

2014-09-25 Publication of CA2906558A1 publication Critical patent/CA2906558A1/fr

Status Abandoned legal-status Critical Current

Links

230000000638 stimulation Effects 0.000 title claims abstract description 378
238000000034 method Methods 0.000 title claims abstract description 129
210000005036 nerve Anatomy 0.000 claims abstract description 336
238000002560 therapeutic procedure Methods 0.000 claims abstract description 143
210000002972 tibial nerve Anatomy 0.000 claims description 109
210000001519 tissue Anatomy 0.000 claims description 92
210000003205 muscle Anatomy 0.000 claims description 90
210000003491 skin Anatomy 0.000 claims description 88
208000002193 Pain Diseases 0.000 claims description 53
230000036407 pain Effects 0.000 claims description 39
230000007830 nerve conduction Effects 0.000 claims description 36
206010046543 Urinary incontinence Diseases 0.000 claims description 32
230000007383 nerve stimulation Effects 0.000 claims description 30
238000001514 detection method Methods 0.000 claims description 27
230000004936 stimulating effect Effects 0.000 claims description 25
208000005793 Restless legs syndrome Diseases 0.000 claims description 23
206010020853 Hypertonic bladder Diseases 0.000 claims description 22
208000009722 Overactive Urinary Bladder Diseases 0.000 claims description 21
208000020629 overactive bladder Diseases 0.000 claims description 21
208000034347 Faecal incontinence Diseases 0.000 claims description 17
239000003814 drug Substances 0.000 claims description 16
229940079593 drug Drugs 0.000 claims description 16
230000001953 sensory effect Effects 0.000 claims description 16
206010052804 Drug tolerance Diseases 0.000 claims description 15
230000005672 electromagnetic field Effects 0.000 claims description 15
230000026781 habituation Effects 0.000 claims description 15
208000000094 Chronic Pain Diseases 0.000 claims description 13
210000000578 peripheral nerve Anatomy 0.000 claims description 13
208000003217 Tetany Diseases 0.000 claims description 12
208000019695 Migraine disease Diseases 0.000 claims description 11
239000000853 adhesive Substances 0.000 claims description 11
230000001070 adhesive effect Effects 0.000 claims description 11
230000035515 penetration Effects 0.000 claims description 11
210000003932 urinary bladder Anatomy 0.000 claims description 10
230000033001 locomotion Effects 0.000 claims description 9
230000004007 neuromodulation Effects 0.000 claims description 9
239000000126 substance Substances 0.000 claims description 9
238000002604 ultrasonography Methods 0.000 claims description 9
230000001684 chronic effect Effects 0.000 claims description 8
206010015037 epilepsy Diseases 0.000 claims description 7
208000008589 Obesity Diseases 0.000 claims description 6
230000003247 decreasing effect Effects 0.000 claims description 6
206010027599 migraine Diseases 0.000 claims description 6
235000020824 obesity Nutrition 0.000 claims description 6
210000005166 vasculature Anatomy 0.000 claims description 6
206010034701 Peroneal nerve palsy Diseases 0.000 claims description 5
210000002683 foot Anatomy 0.000 description 130
238000011282 treatment Methods 0.000 description 85
210000003127 knee Anatomy 0.000 description 48
208000024891 symptom Diseases 0.000 description 37
210000002414 leg Anatomy 0.000 description 33
230000008685 targeting Effects 0.000 description 24
238000004891 communication Methods 0.000 description 22
238000009093 first-line therapy Methods 0.000 description 22
208000004296 neuralgia Diseases 0.000 description 21
230000004044 response Effects 0.000 description 21
239000000463 material Substances 0.000 description 19
230000001225 therapeutic effect Effects 0.000 description 19
210000003423 ankle Anatomy 0.000 description 18
230000009467 reduction Effects 0.000 description 16
230000000694 effects Effects 0.000 description 15
238000010304 firing Methods 0.000 description 14
230000006698 induction Effects 0.000 description 14
230000001939 inductive effect Effects 0.000 description 14
238000003491 array Methods 0.000 description 13
238000013461 design Methods 0.000 description 13
210000003484 anatomy Anatomy 0.000 description 12
208000021722 neuropathic pain Diseases 0.000 description 12
230000002265 prevention Effects 0.000 description 12
239000004020 conductor Substances 0.000 description 11
230000000399 orthopedic effect Effects 0.000 description 11
208000008035 Back Pain Diseases 0.000 description 10
208000004983 Phantom Limb Diseases 0.000 description 10
206010056238 Phantom pain Diseases 0.000 description 10
239000010410 layer Substances 0.000 description 10
230000003387 muscular Effects 0.000 description 10
206010028347 Muscle twitching Diseases 0.000 description 9
239000003795 chemical substances by application Substances 0.000 description 9
230000001965 increasing effect Effects 0.000 description 9
206010036596 premature ejaculation Diseases 0.000 description 9
206010016654 Fibrosis Diseases 0.000 description 8
238000002567 electromyography Methods 0.000 description 8
230000001747 exhibiting effect Effects 0.000 description 8
230000006870 function Effects 0.000 description 8
229910052751 metal Inorganic materials 0.000 description 8
239000002184 metal Substances 0.000 description 8
238000012544 monitoring process Methods 0.000 description 8
206010028836 Neck pain Diseases 0.000 description 7
230000008878 coupling Effects 0.000 description 7
238000010168 coupling process Methods 0.000 description 7
238000005859 coupling reaction Methods 0.000 description 7
208000014674 injury Diseases 0.000 description 7
238000003780 insertion Methods 0.000 description 7
230000037431 insertion Effects 0.000 description 7
210000002988 lumbosacral plexus Anatomy 0.000 description 7
238000001816 cooling Methods 0.000 description 6
230000006378 damage Effects 0.000 description 6
210000005153 frontal cortex Anatomy 0.000 description 6
238000013160 medical therapy Methods 0.000 description 6
230000001537 neural effect Effects 0.000 description 6
210000000056 organ Anatomy 0.000 description 6
208000001375 Facial Neuralgia Diseases 0.000 description 5
206010033799 Paralysis Diseases 0.000 description 5
XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 5
206010003246 arthritis Diseases 0.000 description 5
239000007943 implant Substances 0.000 description 5
230000004118 muscle contraction Effects 0.000 description 5
PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 5
201000008482 osteoarthritis Diseases 0.000 description 5
210000003903 pelvic floor Anatomy 0.000 description 5
230000002829 reductive effect Effects 0.000 description 5
229910052710 silicon Inorganic materials 0.000 description 5
239000010703 silicon Substances 0.000 description 5
208000011580 syndromic disease Diseases 0.000 description 5
-1 wool Polymers 0.000 description 5
206010003694 Atrophy Diseases 0.000 description 4
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
230000037444 atrophy Effects 0.000 description 4
230000008901 benefit Effects 0.000 description 4
208000012790 cranial neuralgia Diseases 0.000 description 4
230000005684 electric field Effects 0.000 description 4
230000005674 electromagnetic induction Effects 0.000 description 4
230000005284 excitation Effects 0.000 description 4
210000003414 extremity Anatomy 0.000 description 4
239000011521 glass Substances 0.000 description 4
230000036541 health Effects 0.000 description 4
238000012423 maintenance Methods 0.000 description 4
238000012986 modification Methods 0.000 description 4
230000004048 modification Effects 0.000 description 4
239000012811 non-conductive material Substances 0.000 description 4
210000001698 popliteal fossa Anatomy 0.000 description 4
230000003252 repetitive effect Effects 0.000 description 4
230000035807 sensation Effects 0.000 description 4
229910001220 stainless steel Inorganic materials 0.000 description 4
239000010935 stainless steel Substances 0.000 description 4
239000000758 substrate Substances 0.000 description 4
238000001356 surgical procedure Methods 0.000 description 4
238000012360 testing method Methods 0.000 description 4
230000008733 trauma Effects 0.000 description 4
208000006820 Arthralgia Diseases 0.000 description 3
208000017667 Chronic Disease Diseases 0.000 description 3
241000736305 Marsilea quadrifolia Species 0.000 description 3
208000012195 Reunion island Larsen syndrome Diseases 0.000 description 3
208000027418 Wounds and injury Diseases 0.000 description 3
230000004913 activation Effects 0.000 description 3
230000001154 acute effect Effects 0.000 description 3
230000009286 beneficial effect Effects 0.000 description 3
238000005516 engineering process Methods 0.000 description 3
230000002550 fecal effect Effects 0.000 description 3
208000002551 irritable bowel syndrome Diseases 0.000 description 3
239000007788 liquid Substances 0.000 description 3
150000002739 metals Chemical class 0.000 description 3
230000005012 migration Effects 0.000 description 3
238000013508 migration Methods 0.000 description 3
229910052759 nickel Inorganic materials 0.000 description 3
230000037361 pathway Effects 0.000 description 3
229920000642 polymer Polymers 0.000 description 3
239000007787 solid Substances 0.000 description 3
210000005070 sphincter Anatomy 0.000 description 3
239000010936 titanium Substances 0.000 description 3
238000002646 transcutaneous electrical nerve stimulation Methods 0.000 description 3
208000020401 Depressive disease Diseases 0.000 description 2
208000001640 Fibromyalgia Diseases 0.000 description 2
208000005615 Interstitial Cystitis Diseases 0.000 description 2
229910021069 Pd—Co Inorganic materials 0.000 description 2
208000023610 Pelvic Floor disease Diseases 0.000 description 2
208000031649 Postoperative Nausea and Vomiting Diseases 0.000 description 2
RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
230000003444 anaesthetic effect Effects 0.000 description 2
238000004873 anchoring Methods 0.000 description 2
230000003542 behavioural effect Effects 0.000 description 2
229920000249 biocompatible polymer Polymers 0.000 description 2
239000004621 biodegradable polymer Substances 0.000 description 2
229920002988 biodegradable polymer Polymers 0.000 description 2
238000001574 biopsy Methods 0.000 description 2
210000000746 body region Anatomy 0.000 description 2
210000000988 bone and bone Anatomy 0.000 description 2
210000004556 brain Anatomy 0.000 description 2
244000309466 calf Species 0.000 description 2
208000003295 carpal tunnel syndrome Diseases 0.000 description 2
210000000845 cartilage Anatomy 0.000 description 2
239000011248 coating agent Substances 0.000 description 2
238000000576 coating method Methods 0.000 description 2
230000000332 continued effect Effects 0.000 description 2
238000012937 correction Methods 0.000 description 2
230000001627 detrimental effect Effects 0.000 description 2
238000002405 diagnostic procedure Methods 0.000 description 2
239000004205 dimethyl polysiloxane Substances 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
208000035475 disorder Diseases 0.000 description 2
230000003828 downregulation Effects 0.000 description 2
238000005530 etching Methods 0.000 description 2
239000012530 fluid Substances 0.000 description 2
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
229910052737 gold Inorganic materials 0.000 description 2
239000010931 gold Substances 0.000 description 2
229940088597 hormone Drugs 0.000 description 2
239000005556 hormone Substances 0.000 description 2
208000015181 infectious disease Diseases 0.000 description 2
238000011221 initial treatment Methods 0.000 description 2
230000030214 innervation Effects 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
230000002045 lasting effect Effects 0.000 description 2
238000002690 local anesthesia Methods 0.000 description 2
230000007257 malfunction Effects 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
238000005259 measurement Methods 0.000 description 2
210000000337 motor cortex Anatomy 0.000 description 2
210000001087 myotubule Anatomy 0.000 description 2
230000002232 neuromuscular Effects 0.000 description 2
229910052763 palladium Inorganic materials 0.000 description 2
206010033675 panniculitis Diseases 0.000 description 2
208000035824 paresthesia Diseases 0.000 description 2
238000001020 plasma etching Methods 0.000 description 2
229910052697 platinum Inorganic materials 0.000 description 2
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
239000004926 polymethyl methacrylate Substances 0.000 description 2
238000003825 pressing Methods 0.000 description 2
230000008569 process Effects 0.000 description 2
238000011084 recovery Methods 0.000 description 2
210000000664 rectum Anatomy 0.000 description 2
230000008929 regeneration Effects 0.000 description 2
238000011069 regeneration method Methods 0.000 description 2
230000008439 repair process Effects 0.000 description 2
230000000717 retained effect Effects 0.000 description 2
230000035939 shock Effects 0.000 description 2
235000012239 silicon dioxide Nutrition 0.000 description 2
239000000377 silicon dioxide Substances 0.000 description 2
229910052709 silver Inorganic materials 0.000 description 2
239000004332 silver Substances 0.000 description 2
210000003625 skull Anatomy 0.000 description 2
210000000278 spinal cord Anatomy 0.000 description 2
210000003594 spinal ganglia Anatomy 0.000 description 2
210000004304 subcutaneous tissue Anatomy 0.000 description 2
230000000153 supplemental effect Effects 0.000 description 2
238000011477 surgical intervention Methods 0.000 description 2
239000003356 suture material Substances 0.000 description 2
210000003813 thumb Anatomy 0.000 description 2
229910052719 titanium Inorganic materials 0.000 description 2
238000012546 transfer Methods 0.000 description 2
210000001364 upper extremity Anatomy 0.000 description 2
230000003827 upregulation Effects 0.000 description 2
230000002485 urinary effect Effects 0.000 description 2
210000001635 urinary tract Anatomy 0.000 description 2
230000008673 vomiting Effects 0.000 description 2
206010001540 Akathisia Diseases 0.000 description 1
208000024827 Alzheimer disease Diseases 0.000 description 1
206010002091 Anaesthesia Diseases 0.000 description 1
206010002383 Angina Pectoris Diseases 0.000 description 1
206010002556 Ankylosing Spondylitis Diseases 0.000 description 1
208000025978 Athletic injury Diseases 0.000 description 1
208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 description 1
208000036864 Attention deficit/hyperactivity disease Diseases 0.000 description 1
206010069632 Bladder dysfunction Diseases 0.000 description 1
208000010392 Bone Fractures Diseases 0.000 description 1
206010006811 Bursitis Diseases 0.000 description 1
206010058019 Cancer Pain Diseases 0.000 description 1
206010008479 Chest Pain Diseases 0.000 description 1
208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
208000028698 Cognitive impairment Diseases 0.000 description 1
229920000742 Cotton Polymers 0.000 description 1
208000012514 Cumulative Trauma disease Diseases 0.000 description 1
206010012289 Dementia Diseases 0.000 description 1
206010012438 Dermatitis atopic Diseases 0.000 description 1
208000032953 Device battery issue Diseases 0.000 description 1
206010064687 Device related infection Diseases 0.000 description 1
208000032131 Diabetic Neuropathies Diseases 0.000 description 1
208000005872 Diffuse Esophageal Spasm Diseases 0.000 description 1
208000012661 Dyskinesia Diseases 0.000 description 1
208000005171 Dysmenorrhea Diseases 0.000 description 1
206010013935 Dysmenorrhoea Diseases 0.000 description 1
208000014094 Dystonic disease Diseases 0.000 description 1
208000000289 Esophageal Achalasia Diseases 0.000 description 1
JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
206010016059 Facial pain Diseases 0.000 description 1
206010017076 Fracture Diseases 0.000 description 1
206010072132 Fracture pain Diseases 0.000 description 1
208000003098 Ganglion Cysts Diseases 0.000 description 1
229920000544 Gore-Tex Polymers 0.000 description 1
208000035895 Guillain-Barré syndrome Diseases 0.000 description 1
206010019233 Headaches Diseases 0.000 description 1
206010019468 Hemiplegia Diseases 0.000 description 1
208000031220 Hemophilia Diseases 0.000 description 1
208000009292 Hemophilia A Diseases 0.000 description 1
208000007514 Herpes zoster Diseases 0.000 description 1
206010020649 Hyperkeratosis Diseases 0.000 description 1
206010020772 Hypertension Diseases 0.000 description 1
XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
206010021518 Impaired gastric emptying Diseases 0.000 description 1
102000004877 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
206010022562 Intermittent claudication Diseases 0.000 description 1
206010023204 Joint dislocation Diseases 0.000 description 1
208000003947 Knee Osteoarthritis Diseases 0.000 description 1
208000007914 Labor Pain Diseases 0.000 description 1
208000035945 Labour pain Diseases 0.000 description 1
206010049567 Miller Fisher syndrome Diseases 0.000 description 1
208000007101 Muscle Cramp Diseases 0.000 description 1
208000008238 Muscle Spasticity Diseases 0.000 description 1
206010050031 Muscle strain Diseases 0.000 description 1
206010028391 Musculoskeletal Pain Diseases 0.000 description 1
208000000112 Myalgia Diseases 0.000 description 1
206010028813 Nausea Diseases 0.000 description 1
208000028389 Nerve injury Diseases 0.000 description 1
208000000693 Neurogenic Urinary Bladder Diseases 0.000 description 1
206010029279 Neurogenic bladder Diseases 0.000 description 1
208000005890 Neuroma Diseases 0.000 description 1
206010030124 Oedema peripheral Diseases 0.000 description 1
206010030136 Oesophageal achalasia Diseases 0.000 description 1
206010030184 Oesophageal spasm Diseases 0.000 description 1
206010033892 Paraplegia Diseases 0.000 description 1
208000000450 Pelvic Pain Diseases 0.000 description 1
206010036376 Postherpetic Neuralgia Diseases 0.000 description 1
208000004550 Postoperative Pain Diseases 0.000 description 1
208000006399 Premature Obstetric Labor Diseases 0.000 description 1
206010066962 Procedural nausea Diseases 0.000 description 1
206010066963 Procedural vomiting Diseases 0.000 description 1
206010037714 Quadriplegia Diseases 0.000 description 1
208000012322 Raynaud phenomenon Diseases 0.000 description 1
229920000297 Rayon Polymers 0.000 description 1
206010038743 Restlessness Diseases 0.000 description 1
208000027790 Rib fracture Diseases 0.000 description 1
208000007613 Shoulder Pain Diseases 0.000 description 1
206010040943 Skin Ulcer Diseases 0.000 description 1
206010040880 Skin irritation Diseases 0.000 description 1
206010072005 Spinal pain Diseases 0.000 description 1
208000005400 Synovial Cyst Diseases 0.000 description 1
239000004809 Teflon Substances 0.000 description 1
229920006362 Teflon® Polymers 0.000 description 1
208000009205 Tinnitus Diseases 0.000 description 1
206010044565 Tremor Diseases 0.000 description 1
206010047249 Venous thrombosis Diseases 0.000 description 1
241000700605 Viruses Species 0.000 description 1
206010047700 Vomiting Diseases 0.000 description 1
208000003728 Vulvodynia Diseases 0.000 description 1
206010069055 Vulvovaginal pain Diseases 0.000 description 1
230000003187 abdominal effect Effects 0.000 description 1
238000005299 abrasion Methods 0.000 description 1
201000000621 achalasia Diseases 0.000 description 1
230000009471 action Effects 0.000 description 1
239000004480 active ingredient Substances 0.000 description 1
208000005298 acute pain Diseases 0.000 description 1
230000002411 adverse Effects 0.000 description 1
230000004075 alteration Effects 0.000 description 1
230000037005 anaesthesia Effects 0.000 description 1
230000002917 arthritic effect Effects 0.000 description 1
201000008937 atopic dermatitis Diseases 0.000 description 1
208000010668 atopic eczema Diseases 0.000 description 1
208000015802 attention deficit-hyperactivity disease Diseases 0.000 description 1
238000005452 bending Methods 0.000 description 1
230000002146 bilateral effect Effects 0.000 description 1
230000000975 bioactive effect Effects 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
230000017531 blood circulation Effects 0.000 description 1
230000008081 blood perfusion Effects 0.000 description 1
238000009534 blood test Methods 0.000 description 1
206010006514 bruxism Diseases 0.000 description 1
230000004663 cell proliferation Effects 0.000 description 1
210000003169 central nervous system Anatomy 0.000 description 1
230000008859 change Effects 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 1
208000010877 cognitive disease Diseases 0.000 description 1
230000001149 cognitive effect Effects 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
238000011340 continuous therapy Methods 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
239000002826 coolant Substances 0.000 description 1
238000002316 cosmetic surgery Methods 0.000 description 1
238000011461 current therapy Methods 0.000 description 1
230000007423 decrease Effects 0.000 description 1
230000007850 degeneration Effects 0.000 description 1
230000003001 depressive effect Effects 0.000 description 1
210000004207 dermis Anatomy 0.000 description 1
230000001066 destructive effect Effects 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
230000003467 diminishing effect Effects 0.000 description 1
238000006073 displacement reaction Methods 0.000 description 1
238000002651 drug therapy Methods 0.000 description 1
206010013781 dry mouth Diseases 0.000 description 1
230000004064 dysfunction Effects 0.000 description 1
208000010118 dystonia Diseases 0.000 description 1
230000002500 effect on skin Effects 0.000 description 1
238000009713 electroplating Methods 0.000 description 1
210000002615 epidermis Anatomy 0.000 description 1
230000002964 excitative effect Effects 0.000 description 1
239000004744 fabric Substances 0.000 description 1
230000001815 facial effect Effects 0.000 description 1
210000000256 facial nerve Anatomy 0.000 description 1
206010016256 fatigue Diseases 0.000 description 1
239000000835 fiber Substances 0.000 description 1
238000011049 filling Methods 0.000 description 1
230000004907 flux Effects 0.000 description 1
230000037406 food intake Effects 0.000 description 1
208000001130 gallstones Diseases 0.000 description 1
208000001288 gastroparesis Diseases 0.000 description 1
238000000227 grinding Methods 0.000 description 1
231100000869 headache Toxicity 0.000 description 1
230000035876 healing Effects 0.000 description 1
208000019622 heart disease Diseases 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
208000012285 hip pain Diseases 0.000 description 1
238000002513 implantation Methods 0.000 description 1
238000001802 infusion Methods 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
230000003993 interaction Effects 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
208000021156 intermittent vascular claudication Diseases 0.000 description 1
208000003243 intestinal obstruction Diseases 0.000 description 1
210000000936 intestine Anatomy 0.000 description 1
230000007794 irritation Effects 0.000 description 1
208000028867 ischemia Diseases 0.000 description 1
208000024765 knee pain Diseases 0.000 description 1
238000013150 knee replacement Methods 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
238000001459 lithography Methods 0.000 description 1
230000007774 longterm Effects 0.000 description 1
238000002653 magnetic therapy Methods 0.000 description 1
239000003550 marker Substances 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
238000002483 medication Methods 0.000 description 1
239000000203 mixture Substances 0.000 description 1
201000006417 multiple sclerosis Diseases 0.000 description 1
208000013465 muscle pain Diseases 0.000 description 1
201000000585 muscular atrophy Diseases 0.000 description 1
230000008693 nausea Effects 0.000 description 1
230000008764 nerve damage Effects 0.000 description 1
210000001640 nerve ending Anatomy 0.000 description 1
210000000118 neural pathway Anatomy 0.000 description 1
230000010004 neural pathway Effects 0.000 description 1
230000001272 neurogenic effect Effects 0.000 description 1
230000000926 neurological effect Effects 0.000 description 1
210000002569 neuron Anatomy 0.000 description 1
201000001119 neuropathy Diseases 0.000 description 1
230000007823 neuropathy Effects 0.000 description 1
210000000929 nociceptor Anatomy 0.000 description 1
231100000344 non-irritating Toxicity 0.000 description 1
238000011369 optimal treatment Methods 0.000 description 1
238000005457 optimization Methods 0.000 description 1
238000013021 overheating Methods 0.000 description 1
229940124583 pain medication Drugs 0.000 description 1
230000008058 pain sensation Effects 0.000 description 1
230000037325 pain tolerance Effects 0.000 description 1
238000000059 patterning Methods 0.000 description 1
230000008447 perception Effects 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
210000001428 peripheral nervous system Anatomy 0.000 description 1
230000002085 persistent effect Effects 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
238000011422 pharmacological therapy Methods 0.000 description 1
238000011458 pharmacological treatment Methods 0.000 description 1
210000002826 placenta Anatomy 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
229920000728 polyester Polymers 0.000 description 1
230000002980 postoperative effect Effects 0.000 description 1
230000035935 pregnancy Effects 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
230000010349 pulsation Effects 0.000 description 1
239000002964 rayon Substances 0.000 description 1
230000000306 recurrent effect Effects 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
210000004994 reproductive system Anatomy 0.000 description 1
230000000284 resting effect Effects 0.000 description 1
206010039073 rheumatoid arthritis Diseases 0.000 description 1
201000000980 schizophrenia Diseases 0.000 description 1
230000021317 sensory perception Effects 0.000 description 1
208000007056 sickle cell anemia Diseases 0.000 description 1
239000002356 single layer Substances 0.000 description 1
230000036556 skin irritation Effects 0.000 description 1
231100000475 skin irritation Toxicity 0.000 description 1
231100000019 skin ulcer Toxicity 0.000 description 1
210000002460 smooth muscle Anatomy 0.000 description 1
239000000243 solution Substances 0.000 description 1
238000000807 solvent casting Methods 0.000 description 1
210000004514 sphincter of oddi Anatomy 0.000 description 1
208000020431 spinal cord injury Diseases 0.000 description 1
208000002320 spinal muscular atrophy Diseases 0.000 description 1
210000000434 stratum corneum Anatomy 0.000 description 1
238000005728 strengthening Methods 0.000 description 1
210000004003 subcutaneous fat Anatomy 0.000 description 1
229920002994 synthetic fiber Polymers 0.000 description 1
210000001738 temporomandibular joint Anatomy 0.000 description 1
210000000115 thoracic cavity Anatomy 0.000 description 1
231100000886 tinnitus Toxicity 0.000 description 1
208000037816 tissue injury Diseases 0.000 description 1
238000012549 training Methods 0.000 description 1
230000009466 transformation Effects 0.000 description 1
210000003901 trigeminal nerve Anatomy 0.000 description 1
206010044652 trigeminal neuralgia Diseases 0.000 description 1
210000004291 uterus Anatomy 0.000 description 1
238000002255 vaccination Methods 0.000 description 1
230000002747 voluntary effect Effects 0.000 description 1
230000003442 weekly effect Effects 0.000 description 1
238000004804 winding Methods 0.000 description 1
210000002268 wool Anatomy 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/004—Magnetotherapy specially adapted for a specific therapy
- A61N2/006—Magnetotherapy specially adapted for a specific therapy for magnetic stimulation of nerve tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0456—Specially adapted for transcutaneous electrical nerve stimulation [TENS]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36003—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of motor muscles, e.g. for walking assistance
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/3603—Control systems
- A61N1/36031—Control systems using physiological parameters for adjustment
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/3603—Control systems
- A61N1/36034—Control systems specified by the stimulation parameters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/004—Magnetotherapy specially adapted for a specific therapy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Radiology & Medical Imaging (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Biophysics (AREA)
Heart & Thoracic Surgery (AREA)
Physiology (AREA)
Neurology (AREA)
Physical Education & Sports Medicine (AREA)
Electrotherapy Devices (AREA)
Magnetic Treatment Devices (AREA)

CA2906558A 2013-03-15 2014-03-13 Procede et appareil pour stimulation transdermique sur les surfaces palmaires et plantaires Abandoned CA2906558A1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US13/840,936 US9339641B2 (en)	2006-01-17	2013-03-15	Method and apparatus for transdermal stimulation over the palmar and plantar surfaces
US13/840,936		2013-03-15
PCT/US2014/025718 WO2014151431A2 (fr)	2013-03-15	2014-03-13	Procédé et appareil pour stimulation transdermique sur les surfaces palmaires et plantaires

Publications (1)

Publication Number	Publication Date
CA2906558A1 true CA2906558A1 (fr)	2014-09-25

Family

ID=51581640

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2906558A Abandoned CA2906558A1 (fr)	2013-03-15	2014-03-13	Procede et appareil pour stimulation transdermique sur les surfaces palmaires et plantaires

Country Status (4)

Country	Link
EP (1)	EP2968910A4 (fr)
JP (1)	JP2016515869A (fr)
CA (1)	CA2906558A1 (fr)
WO (1)	WO2014151431A2 (fr)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9339641B2 (en)	2006-01-17	2016-05-17	Emkinetics, Inc.	Method and apparatus for transdermal stimulation over the palmar and plantar surfaces
US10786669B2 (en)	2006-10-02	2020-09-29	Emkinetics, Inc.	Method and apparatus for transdermal stimulation over the palmar and plantar surfaces
DE102012013534B3 (de)	2012-07-05	2013-09-19	Tobias Sokolowski	Vorrichtung für repetitive Nervenstimulation zum Abbau von Fettgewebe mittels induktiver Magnetfelder
EP3498332B1 (fr)	2013-01-21	2021-07-14	Cala Health, Inc.	Dispositifs de contrôle de tremblements
US12453853B2 (en)	2013-01-21	2025-10-28	Cala Health, Inc.	Multi-modal stimulation for treating tremor
WO2014151431A2 (fr) *	2013-03-15	2014-09-25	Emkinetics, Inc.	Procédé et appareil pour stimulation transdermique sur les surfaces palmaires et plantaires
EP3148640B1 (fr)	2014-06-02	2024-01-24	Cala Health, Inc.	Systèmes de stimulation de nerf périphérique pour traiter un tremblement
WO2021134085A1 (fr)	2019-12-28	2021-07-01	Jeff Bennett	Appareil et procédé de traitement d'un événement physiologique qui approche et d'augmentation d'une intensité de l'événement
RU2017114381A (ru) *	2014-10-31	2018-12-03	Авент, Инк.	Способ и система для мониторинга и лечения заболевания посредством стимуляции заднего большеберцового нерва
WO2016106182A1 (fr)	2014-12-23	2016-06-30	University Of Pittsburgh - Of The Commonwealth System Of Higher Education	Dispositifs, systèmes et méthodes de traitement de troubles urologiques et gastro-intestinaux par stimulation électrique du pied
US11491342B2 (en)	2015-07-01	2022-11-08	Btl Medical Solutions A.S.	Magnetic stimulation methods and devices for therapeutic treatments
CA2988586A1 (fr)	2015-06-10	2016-12-15	Cala Health, Inc.	Systeme de neuromodulation pour la stimulation des nerfs peripheriques a l'aide d'une unite de therapie detachable
US10695575B1 (en)	2016-05-10	2020-06-30	Btl Medical Technologies S.R.O.	Aesthetic method of biological structure treatment by magnetic field
US11266850B2 (en)	2015-07-01	2022-03-08	Btl Healthcare Technologies A.S.	High power time varying magnetic field therapy
US20180001107A1 (en)	2016-07-01	2018-01-04	Btl Holdings Limited	Aesthetic method of biological structure treatment by magnetic field
CN108135537B (zh)	2015-07-31	2021-11-16	卡拉健康公司	用于治疗骨关节炎的系统、装置和方法
CN108348746B (zh)	2015-09-23	2021-10-12	卡拉健康公司	用于手指或手中的周围神经刺激以治疗手震颤的系统和方法
US11253717B2 (en)	2015-10-29	2022-02-22	Btl Healthcare Technologies A.S.	Aesthetic method of biological structure treatment by magnetic field
EP3405251A4 (fr)	2016-01-21	2019-08-28	Cala Health, Inc.	Systèmes, procédés et dispositifs de neuromodulation périphérique pour le traitement de maladies associées à une hyperactivitévésicale
US11247039B2 (en)	2016-05-03	2022-02-15	Btl Healthcare Technologies A.S.	Device including RF source of energy and vacuum system
US11464993B2 (en)	2016-05-03	2022-10-11	Btl Healthcare Technologies A.S.	Device including RF source of energy and vacuum system
US11534619B2 (en)	2016-05-10	2022-12-27	Btl Medical Solutions A.S.	Aesthetic method of biological structure treatment by magnetic field
US10583287B2 (en)	2016-05-23	2020-03-10	Btl Medical Technologies S.R.O.	Systems and methods for tissue treatment
JP6100985B1 (ja) *	2016-06-23	2017-03-22	正悦袴田	家庭用電気治療器
US10556122B1 (en)	2016-07-01	2020-02-11	Btl Medical Technologies S.R.O.	Aesthetic method of biological structure treatment by magnetic field
IL264116B2 (en)	2016-07-08	2024-01-01	Cala Health Inc	Systems and methods for stimulating n nerves with exactly n electrodes and improved dry electrodes
US11141219B1 (en)	2016-08-16	2021-10-12	BTL Healthcare Technologies, a.s.	Self-operating belt
CN117959601A (zh)	2016-08-25	2024-05-03	卡拉健康公司	通过周围神经刺激治疗心脏机能障碍的系统和方法
US11638814B2 (en)	2016-10-05	2023-05-02	Tesla Medical S.R.O.	Method for neuromodulation treatment of neurodegenerative disease
US11839762B2 (en)	2016-10-05	2023-12-12	Stimvia S.R.O.	Neuromodulation medical treatment device
ES2794562T3 (es) *	2016-10-05	2020-11-18	Tesla Medical S R O	Dispositivo de tratamiento por neuromodulación
US11896824B2 (en)	2016-10-05	2024-02-13	Stimvia S.R.O.	Method for neuromodulation treatment of low urinary tract dysfunction
US12011290B2 (en) *	2016-11-17	2024-06-18	Brainlab Ag	Time-synchronized deep brain stimulation optimization
MX2019007714A (es) *	2016-12-27	2019-09-09	Avent Inc	Articulo y metodo para tratar neuropatia diabetica periferica.
TR201620482A2 (tr) *	2016-12-31	2017-10-23	Univ Istanbul Teknik	Elektroni̇k teksti̇l tabanli romatoi̇d artri̇t terapi̇ eldi̇veni̇
EP3606604A4 (fr)	2017-04-03	2020-12-16	Cala Health, Inc.	Systèmes, procédés et dispositifs de neuromodulation périphérique pour le traitement de maladies associées à une hyperactivitévésicale
EP3415199B1 (fr) *	2017-05-22	2024-12-11	BTL Medical Solutions a.s.	Dispositif esthétique de traitement de structure biologique par champ magnétique
EP3740274A4 (fr)	2018-01-17	2021-10-27	Cala Health, Inc.	Systèmes et méthodes de traitement d'une maladie intestinale inflammatoire par stimulation du nerf périphérique
US11446490B2 (en)	2019-04-05	2022-09-20	Tesla Medical S.R.O.	Method for a neuromodulation treatment
US12156689B2 (en)	2019-04-11	2024-12-03	Btl Medical Solutions A.S.	Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy
US12558146B2 (en)	2019-04-11	2026-02-24	Btl Medical Solutions A.S.	Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy
ES2988162T3 (es)	2019-04-11	2024-11-19	Btl Medical Solutions A S	Dispositivos para el tratamiento estético de estructuras biológicas mediante radiofrecuencia y energía magnética
CN112242051A (zh) *	2019-07-19	2021-01-19	江苏安惠医疗器械有限公司	子端机和康健装置以及康健装置的控制方法
US12251560B1 (en)	2019-08-13	2025-03-18	Cala Health, Inc.	Connection quality determination for wearable neurostimulation systems
US11890468B1 (en)	2019-10-03	2024-02-06	Cala Health, Inc.	Neurostimulation systems with event pattern detection and classification
EP4146335B1 (fr)	2020-05-04	2024-11-13	BTL Healthcare Technologies a.s.	Dispositif pour traitement automatisé d'un patient
US11878167B2 (en)	2020-05-04	2024-01-23	Btl Healthcare Technologies A.S.	Device and method for unattended treatment of a patient
GB202012880D0 (en) *	2020-08-18	2020-09-30	Sky Medical Tech Ltd	Treatment of ischemia
WO2022072385A2 (fr)	2020-09-30	2022-04-07	Boston Scientific Scimed Inc	Forme d'onde de traitement préalable d'électroporation irréversible
CN112674920A (zh) *	2020-12-23	2021-04-20	江苏省人民医院（南京医科大学第一附属医院）	一种医用截肢患者幻肢痛体验装置
WO2023062563A1 (fr)	2021-10-13	2023-04-20	Btl Medical Solutions A.S.	Dispositifs de traitement esthétique de structures biologiques par énergie radiofréquence et magnétique
US11896816B2 (en)	2021-11-03	2024-02-13	Btl Healthcare Technologies A.S.	Device and method for unattended treatment of a patient
US20250152958A1 (en) *	2022-02-18	2025-05-15	Nipro Corporation	Medical apparatus
CN116850027A (zh) *	2023-08-08	2023-10-10	深圳市安特贝尔科技有限公司	基于生物反馈的深层肌肉刺激物理治疗设备及控制方法
CN118022183B (zh) *	2024-04-08	2024-06-07	湖南臻和亦康医疗用品有限公司	一种锂电池组快拆式除颤仪
US12564726B1 (en)	2024-10-08	2026-03-03	Btl Medical Solutions A.S.	Devices and methods for application of a magnetic field to the nervous system

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5158080A (en) *	1990-11-08	1992-10-27	Medtronic, Inc.	Muscle tone
GB9321086D0 (en) *	1993-10-13	1993-12-01	Univ Alberta	Hand stimulator
US5851191A (en) *	1997-07-01	1998-12-22	Neurometrix, Inc.	Apparatus and methods for assessment of neuromuscular function
US6735474B1 (en) *	1998-07-06	2004-05-11	Advanced Bionics Corporation	Implantable stimulator system and method for treatment of incontinence and pain
ATE296575T1 (de) *	2000-01-21	2005-06-15	Instrumentarium Corp	Herstellungsverfahren für eine medizinische elektrode
US6912417B1 (en) *	2002-04-05	2005-06-28	Ichor Medical Systmes, Inc.	Method and apparatus for delivery of therapeutic agents
US7089061B2 (en) *	2002-08-27	2006-08-08	Abbott Laboratories	Device and method for nausea suppression
WO2004080528A2 (fr) *	2003-03-06	2004-09-23	Afferent Corporation	Procede et appareil pour ameliorer l'equilibre et la demarche de l'humain et prevenir des blessures au pied
US8140164B2 (en) *	2003-10-15	2012-03-20	Rmx, Llc	Therapeutic diaphragm stimulation device and method
US7979137B2 (en) *	2004-02-11	2011-07-12	Ethicon, Inc.	System and method for nerve stimulation
JP2008531138A (ja) *	2005-03-02	2008-08-14	コンティネンスコントロールシステムズインターナショナルプロプライエタリーリミテッド	失禁を治療するための改良された方法および装置
US20100318009A1 (en) *	2005-12-16	2010-12-16	Solomon Tony Stanley	Therapeutic device that provides stimulation to an immobilized extremity
US9339641B2 (en) *	2006-01-17	2016-05-17	Emkinetics, Inc.	Method and apparatus for transdermal stimulation over the palmar and plantar surfaces
WO2011053607A1 (fr) *	2009-10-26	2011-05-05	Emkinetics, Inc.	Procédé et appareil pour la stimulation électromagnétique d'un nerf, d'un muscle, et de tissus de l'organisme
US7801603B2 (en) *	2006-09-01	2010-09-21	Cardiac Pacemakers, Inc.	Method and apparatus for optimizing vagal nerve stimulation using laryngeal activity
US7634315B2 (en) *	2007-05-31	2009-12-15	Pacesetter, Inc.	Techniques to monitor and trend nerve damage and recovery
CA2727498C (fr) *	2008-07-02	2020-04-21	Niveus Medical, Inc.	Systemes et procedes de stimulation musculaire automatique
JP2013500080A (ja) *	2009-07-23	2013-01-07	エムキネティクス，インコーポレイテッド	伝導性コイルのための冷却システムおよび方法
WO2011041526A2 (fr) *	2009-10-01	2011-04-07	University Of Pittsburgh-Of The Commonwealth System Of Higher Education	Méthode non invasive pour traiter les troubles urologiques et gastro-intestinaux
US8880178B2 (en) *	2010-06-04	2014-11-04	University Health Network	Functional electrical stimulation device and system, and use thereof
US8452410B2 (en) *	2010-09-07	2013-05-28	Aalborg Universitet	Method and device for reflex-based functional gait training
WO2014151431A2 (fr) *	2013-03-15	2014-09-25	Emkinetics, Inc.	Procédé et appareil pour stimulation transdermique sur les surfaces palmaires et plantaires

2014
- 2014-03-13 WO PCT/US2014/025718 patent/WO2014151431A2/fr not_active Ceased
- 2014-03-13 EP EP14770365.6A patent/EP2968910A4/fr not_active Withdrawn
- 2014-03-13 CA CA2906558A patent/CA2906558A1/fr not_active Abandoned
- 2014-03-13 JP JP2016501950A patent/JP2016515869A/ja active Pending

Also Published As

Publication number	Publication date
JP2016515869A (ja)	2016-06-02
EP2968910A2 (fr)	2016-01-20
EP2968910A4 (fr)	2016-11-02
WO2014151431A2 (fr)	2014-09-25
WO2014151431A3 (fr)	2014-11-13

Legal Events

Date	Code	Title	Description
2018-04-24	FZDE	Dead	Effective date: 20180313

Publication	Publication Date	Title
US12226632B2 (en)	2025-02-18	Method and apparatus for transdermal stimulation over the palmar and plantar surfaces
US12083334B2 (en)	2024-09-10	Methods and devices for performing electrical stimulation to treat dysmenorrhea or menstrual cramps
US9630004B2 (en)	2017-04-25	Method and apparatus for transdermal stimulation over the palmar and plantar surfaces
AU2011305581B2 (en)	2016-05-05	Method and apparatus for transdermal stimulation over the palmar and plantar surfaces
US9757584B2 (en)	2017-09-12	Methods and devices for performing electrical stimulation to treat various conditions
CA2906558A1 (fr)	2014-09-25	Procede et appareil pour stimulation transdermique sur les surfaces palmaires et plantaires
US20180050216A9 (en)	2018-02-22	Methods and devices for treating migraines with electromagnetic stimulation
US20160074671A1 (en)	2016-03-17	Method of treating or alleviating a patient with incontinence
WO2011011748A1 (fr)	2011-01-27	Procédé et appareil de thérapie par induction magnétique